SYRS

Syros Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Syros Pharmaceuticals Inc SYRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0173 1.8% 0.98 19:37:29
Open Price Low Price High Price Close Price Prev Close
0.93 0.91 0.98 0.91 0.9627
more quote information »

Recent News

Date Time Source Heading
7/01/202216:01BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
6/08/202207:30BWSyros to Present at JMP Securities Life Sciences Conference
6/07/202219:15TRMNSyros Pharmaceuticals (SYRS) Received its Third Buy in a Row
6/07/202207:32EDGARCurrent Report Filing (8-k)
6/03/202216:01BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
6/02/202219:11EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202219:11EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202219:10EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202219:08EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202219:08EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202219:07EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202216:55TRMNSyros Pharmaceuticals (SYRS) Receives a Buy from Alliance..
5/16/202207:30BWSyros Pharmaceuticals Reports First Quarter 2022 Financial..
5/16/202207:03EDGARQuarterly Report (10-q)
5/09/202207:30BWSyros to Report First Quarter 2022 Financial Results on..
4/29/202216:01BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
4/25/202210:29TRMNThese 2 Penny Stocks Could Rally to $15 (Or More), Says Roth..
4/21/202207:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/20/202211:01TRMNThese 2 Penny Stocks Could Rally to $15 (Or More), Says Roth..
4/11/202209:03EDGARAmended Statement of Ownership (sc 13g/a)
4/08/202220:30TRMNBrookline Capital Markets Thinks Syros Pharmaceuticals’..
4/08/202213:00BWSyros Presents New Preclinical Data on its CDK12 Inhibitor..
4/01/202216:01BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
3/16/202211:35TRMNAlliance Global Partners Sticks to Their Buy Rating for..
3/16/202206:56TRMNH.C. Wainwright Thinks Syros Pharmaceuticals’ Stock is Going..
3/15/202212:45TRMNJMP Securities Keeps a Buy Rating on Syros Pharmaceuticals..
3/15/202208:03EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/15/202207:37SEEKSyros Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08,..
3/15/202207:32BWSyros Reports Fourth Quarter and Full Year 2021 Financial..
3/15/202207:28EDGARAnnual Report (10-k)
3/14/202212:28SEEKSyros Pharmaceuticals Q4 2021 Earnings Preview
3/09/202207:30BWSyros to Report Fourth Quarter and Full Year 2021 Financial..
3/08/202216:31BWSyros to Present New Preclinical Data on its CDK12 Inhibitor..
3/08/202214:15TRMNJMP Securities Thinks Syros Pharmaceuticals’ Stock is Going..
3/08/202207:02EDGARCurrent Report Filing (8-k)
2/28/202207:30BWSyros to Participate in Upcoming Virtual Investor..
2/17/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202216:09EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
2/14/202206:42EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202216:27EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202206:29EDGARStatement of Ownership (sc 13g)
2/09/202210:05EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202206:14EDGARAmended Statement of Ownership (sc 13g/a)
2/02/202217:16DJNSyros Shares Up 10% After Getting FDA Orphan Drug..
2/02/202216:09SEEKSyros rises 13% as tamibarotene gets FDA orphan drug status..
2/02/202216:01BWSyros Receives FDA Orphan Drug Designation for Tamibarotene..
1/11/202203:51SEEKSyros outlines clinical updates and 2022 goals
Your Recent History
NASDAQ
SYRS
Syros Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220702 03:09:53